RxDoctor Payments Data

Derek Howell, PA

Surgical · Norfolk, NENPI 1053364299

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $2,375 of the $3,296 with a category attached, or 72.1%. Terumo Cardiovascular Systems Corporation accounts for 82.3% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2022 at $2,914 and has fallen 92.6% since, to $217 in 2025. Among surgical clinicians in NE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,296in general payments, 2019–2025

Across 24 payments — averaging $137.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Terumo Cardiovascular Systems Corporation$3K
  • Organogenesis Inc.$155
  • Arthrex$106
  • Zimmer Biomet$74
  • Integra Lifesciences Corporation$53
  • Lemaitre Vascular, Inc.$43
  • plus $152 from 8 others

What the payments were for

  • Consulting fees$2,37572%
  • Travel & lodging$3049%
  • Food & beverage$61719%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,296 in reported general payments places this provider in the 90th percentile of 101 surgical providers in Nebraska.

See all surgical providers in Nebraska

Medicare billing

Part B allowed, 2024
$37,511
Medicare patients
157
Services billed
786

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Monohydrate21$320
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav25$200
Levofloxacin14$131

Paid to pharmacies, not to this prescriber.

Other surgical in Norfolk

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →